Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119079155 | 11907915 | 5 | F | 201401 | 20160628 | 20160111 | 20160712 | EXP | US-JNJFOC-20160105172 | JANSSEN | 74.03 | YR | E | F | Y | 0.00000 | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119079155 | 11907915 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 119079155 | 11907915 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 119079155 | 11907915 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 119079155 | 11907915 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 119079155 | 11907915 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 119079155 | 11907915 | 6 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 202439 | 20 | MG | TABLET | |||||
| 119079155 | 11907915 | 7 | SS | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | U | 0 | SPRAY | |||||||||
| 119079155 | 11907915 | 8 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119079155 | 11907915 | 9 | C | LYRICA | PREGABALIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119079155 | 11907915 | 10 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119079155 | 11907915 | 11 | C | MULTAQ | DRONEDARONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119079155 | 11907915 | 12 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 119079155 | 11907915 | 13 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119079155 | 11907915 | 1 | Cerebrovascular accident prophylaxis |
| 119079155 | 11907915 | 2 | Cerebrovascular accident prophylaxis |
| 119079155 | 11907915 | 3 | Cerebrovascular accident prophylaxis |
| 119079155 | 11907915 | 4 | Atrial fibrillation |
| 119079155 | 11907915 | 5 | Atrial fibrillation |
| 119079155 | 11907915 | 6 | Atrial fibrillation |
| 119079155 | 11907915 | 7 | Nasal dryness |
| 119079155 | 11907915 | 8 | Product used for unknown indication |
| 119079155 | 11907915 | 9 | Product used for unknown indication |
| 119079155 | 11907915 | 10 | Product used for unknown indication |
| 119079155 | 11907915 | 11 | Product used for unknown indication |
| 119079155 | 11907915 | 12 | Product used for unknown indication |
| 119079155 | 11907915 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119079155 | 11907915 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119079155 | 11907915 | Ear haemorrhage | |
| 119079155 | 11907915 | Epistaxis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119079155 | 11907915 | 1 | 201302 | 201401 | 0 | |
| 119079155 | 11907915 | 2 | 201403 | 201510 | 0 | |
| 119079155 | 11907915 | 3 | 2014 | 201403 | 0 | |
| 119079155 | 11907915 | 4 | 201302 | 201401 | 0 | |
| 119079155 | 11907915 | 5 | 201403 | 201510 | 0 | |
| 119079155 | 11907915 | 6 | 2014 | 201403 | 0 |